Literature DB >> 16558473

Exercise-induced vasodepressor syncope in a collegiate wrestler: a case study.

J Hand.   

Abstract

OBJECTIVE: To present the case of an 18-year-old collegiate wrestler diagnosed with vasodepressor syncope.
BACKGROUND: Vasodepressor syncope and the pathophysiologic mechanisms responsible are not fully understood. It is postulated that a sudden, rapid reduction in venous return to the heart allows for quite forceful ventricular contractions. Hypotension, bradycardia, and possible cerebral hypoxia may result, which could cause loss of consciousness. DIFFERENTIAL DIAGNOSIS: Cardiovascular, neurologic, metabolic, and psychogenic causes. TREATMENT: Pharmacologic therapy of fludrocortisone acetate and potassium chloride was effective. The athlete returned to full activity without restrictions and remained symptom free throughout the remainder of the season. UNIQUENESS: Vasodepressor syncope is usually associated with full syncope. However, this 18-year-old wrestler never fully lost consciousness. His symptoms occurred primarily with exercise.
CONCLUSIONS: The athletic trainer should consider exercise- induced vasodepressor syncope as a possible etiology for those athletes who present with presyncopal episodes.

Entities:  

Year:  1997        PMID: 16558473      PMCID: PMC1320355     

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  17 in total

1.  Reproducibility of head upright tilt table test results in patients with syncope.

Authors:  B P Grubb; D Wolfe; P Temesy-Armos; H Hahn; L Elliott
Journal:  Pacing Clin Electrophysiol       Date:  1992-10       Impact factor: 1.976

2.  Syncope in young adults: evidence for a combined medical and psychiatric approach.

Authors:  D Koenig; M Linzer; M Pontinen; G W Divine
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

3.  Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope.

Authors:  W A Scott; G Pongiglione; B I Bromberg; M S Schaffer; B J Deal; F A Fish; M Dick
Journal:  Am J Cardiol       Date:  1995-08-15       Impact factor: 2.778

4.  Spontaneous and induced vasodepressor/vasovagal syncope in hypertrophic cardiomyopathy.

Authors:  G Buja; P Melacini; A Folino; M Miorelli; A Nava
Journal:  Clin Cardiol       Date:  1992-05       Impact factor: 2.882

5.  Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope.

Authors:  B P Grubb; D A Wolfe; D Samoil; P Temesy-Armos; H Hahn; L Elliott
Journal:  Pacing Clin Electrophysiol       Date:  1993-03       Impact factor: 1.976

6.  Sensitivity and specificity of the tilt table test in young patients with unexplained syncope.

Authors:  F M Fouad; S Sitthisook; G Vanerio; J Maloney; M Okabe; F Jaeger; M Schluchter; J D Maloney
Journal:  Pacing Clin Electrophysiol       Date:  1993-03       Impact factor: 1.976

7.  Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.

Authors:  H Calkins; M Seifert; F Morady
Journal:  Am Heart J       Date:  1995-06       Impact factor: 4.749

8.  The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents.

Authors:  B P Grubb; P Temesy-Armos; J Moore; D Wolfe; H Hahn; L Elliott
Journal:  Pacing Clin Electrophysiol       Date:  1992-05       Impact factor: 1.976

9.  Head-upright tilt-table testing: a useful tool in the evaluation and management of recurrent vertigo of unknown origin associated with near-syncope or syncope.

Authors:  B P Grubb; A M Rubin; D Wolfe; P Temesy-Armos; H Hahn; L Elliott
Journal:  Otolaryngol Head Neck Surg       Date:  1992-10       Impact factor: 3.497

Review 10.  Syncope in athletes.

Authors:  C C Williams; D T Bernhardt
Journal:  Sports Med       Date:  1995-03       Impact factor: 11.136

View more
  1 in total

Review 1.  Blood pressure regulation X: what happens when the muscle pump is lost? Post-exercise hypotension and syncope.

Authors:  John R Halliwill; Dylan C Sieck; Steven A Romero; Tahisha M Buck; Matthew R Ely
Journal:  Eur J Appl Physiol       Date:  2013-11-07       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.